- Home
- Chemicals & Materials
- Natural Killer Cells Therapeutics Market
Natural Killer Cells Therapeutics Market Size, Share, Growth, and Industry Analysis, By Types (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders), By Applications Covered (NK Cell Therapies, NK Cell Directed Antibodies) and Regional Forecast to 2033
- Summary
- TOC
- Drivers & Opportunity
- Segmentation
- Regional Outlook
- Key Players
- Methodology
- FAQ
- Request a FREE Sample PDF
Detailed TOC of Global Natural Killer Cells Therapeutics Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2025 to 2033
Table of Content
1 Market Overview
1.1 Product Overview and Scope of Natural Killer Cells Therapeutics
1.1.1 Market Coverage
1.1.2 Market Definition
1.2 Market Analysis by Type
1.3 Market Analysis by Application
1.4 Market Analysis by Region
1.4.1 Global Natural Killer Cells Therapeutics Market Size (Revenue) and CAGR (%) Comparison by Region (2018-2025)
1.4.2 United States Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.3 Europe Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.4 China Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.5 Japan Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.6 India Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.7 Southeast Asia Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.8 Latin America Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.4.9 Middle East and Africa Natural Killer Cells Therapeutics Market Status and Prospect (2018-2025)
1.5 Global Natural Killer Cells Therapeutics Market Size and Forecast
1.5.1 Global Natural Killer Cells Therapeutics Revenue ($) (2018-2033)
1.5.2 Global Natural Killer Cells Therapeutics Sales (2018-2033)
1.5.3 Global Natural Killer Cells Therapeutics Average Price (2018-2033)
2 Players Profiles
2.1 Chinese PLA General Hospital
2.1.1 Chinese PLA General Hospital Company Profiles
2.1.2 Chinese PLA General Hospital Natural Killer Cells Therapeutics Product and Services
2.1.3 Chinese PLA General Hospital Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.1.4 Chinese PLA General Hospital Recent Developments/Updates
2.2 Case Comprehensive Cancer Center
2.2.1 Case Comprehensive Cancer Center Company Profiles
2.2.2 Case Comprehensive Cancer Center Natural Killer Cells Therapeutics Product and Services
2.2.3 Case Comprehensive Cancer Center Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.2.4 Case Comprehensive Cancer Center Recent Developments/Updates
2.3 Baylor College of Medicine
2.3.1 Baylor College of Medicine Company Profiles
2.3.2 Baylor College of Medicine Natural Killer Cells Therapeutics Product and Services
2.3.3 Baylor College of Medicine Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.3.4 Baylor College of Medicine Recent Developments/Updates
2.4 Cyto-Sen Therapeutics
2.4.1 Cyto-Sen Therapeutics Company Profiles
2.4.2 Cyto-Sen Therapeutics Natural Killer Cells Therapeutics Product and Services
2.4.3 Cyto-Sen Therapeutics Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.4.4 Cyto-Sen Therapeutics Recent Developments/Updates
2.5 Allife Medical Science and Technology
2.5.1 Allife Medical Science and Technology Company Profiles
2.5.2 Allife Medical Science and Technology Natural Killer Cells Therapeutics Product and Services
2.5.3 Allife Medical Science and Technology Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.5.4 Allife Medical Science and Technology Recent Developments/Updates
2.6 Celularity
2.6.1 Celularity Company Profiles
2.6.2 Celularity Natural Killer Cells Therapeutics Product and Services
2.6.3 Celularity Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.6.4 Celularity Recent Developments/Updates
2.7 CiMass
2.7.1 CiMass Company Profiles
2.7.2 CiMass Natural Killer Cells Therapeutics Product and Services
2.7.3 CiMass Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.7.4 CiMass Recent Developments/Updates
2.8 CellProtect Nordic Pharmaceuticals
2.8.1 CellProtect Nordic Pharmaceuticals Company Profiles
2.8.2 CellProtect Nordic Pharmaceuticals Natural Killer Cells Therapeutics Product and Services
2.8.3 CellProtect Nordic Pharmaceuticals Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.8.4 CellProtect Nordic Pharmaceuticals Recent Developments/Updates
2.9 Asan Medical Center
2.9.1 Asan Medical Center Company Profiles
2.9.2 Asan Medical Center Natural Killer Cells Therapeutics Product and Services
2.9.3 Asan Medical Center Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.9.4 Asan Medical Center Recent Developments/Updates
2.10 Cytovac
2.10.1 Cytovac Company Profiles
2.10.2 Cytovac Natural Killer Cells Therapeutics Product and Services
2.10.3 Cytovac Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.10.4 Cytovac Recent Developments/Updates
2.11 Capital Medical University
2.11.1 Capital Medical University Company Profiles
2.11.2 Capital Medical University Natural Killer Cells Therapeutics Product and Services
2.11.3 Capital Medical University Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.11.4 Capital Medical University Recent Developments/Updates
2.12 Catholic University of Korea
2.12.1 Catholic University of Korea Company Profiles
2.12.2 Catholic University of Korea Natural Killer Cells Therapeutics Product and Services
2.12.3 Catholic University of Korea Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.12.4 Catholic University of Korea Recent Developments/Updates
2.13 Anhui Provincial Hospital
2.13.1 Anhui Provincial Hospital Company Profiles
2.13.2 Anhui Provincial Hospital Natural Killer Cells Therapeutics Product and Services
2.13.3 Anhui Provincial Hospital Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.13.4 Anhui Provincial Hospital Recent Developments/Updates
2.14 Cell Medica
2.14.1 Cell Medica Company Profiles
2.14.2 Cell Medica Natural Killer Cells Therapeutics Product and Services
2.14.3 Cell Medica Natural Killer Cells Therapeutics Sales, Price, Revenue ($), Gross Margin
2.14.4 Cell Medica Recent Developments/Updates
3 Competitive Environment: by Players
3.1 Global Natural Killer Cells Therapeutics Revenue ($) and Market Share of Key Players
3.2 Global Natural Killer Cells Therapeutics Sales and Market Share of Key Players
3.3 Global Natural Killer Cells Therapeutics Average Price by Players
3.4 Top 3 Natural Killer Cells Therapeutics Manufacturer Market Share in 2022
3.5 Top 5 Natural Killer Cells Therapeutics Manufacturer Market Share in 2022
3.6 Mergers & Acquisitions, Expansion
4 Industry Chain Analysis
4.1 Upstream Raw Material Suppliers of Natural Killer Cells Therapeutics Analysis
4.2 Manufacturing Cost Structure Analysis
4.2.1 Production Process Analysis
4.2.2 Manufacturing Cost Structure of Natural Killer Cells Therapeutics
4.2.3 Raw Material Cost of Natural Killer Cells Therapeutics
4.2.4 Labor Cost of Natural Killer Cells Therapeutics
4.3 Natural Killer Cells Therapeutics Industrial Chain Analysis
4.4 Major Distributors by Region
4.5 Customer Analysis
5 Natural Killer Cells Therapeutics Market Dynamic and Trends, Marketing Strategy Analysis
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Challenges
5.5 Industry Development Trends under Global Inflation
5.6 Impact of Russia and Ukraine War
5.7 Industry News and Policies by Regions
5.7.1 Natural Killer Cells Therapeutics Industry News
5.7.2 Natural Killer Cells Therapeutics Industry Policies
5.8 Porters Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Bargaining Power of Suppliers
5.8.3 Bargaining Power of Buyers
5.8.4 Threat of Substitutes
5.8.5 Competitive Rivalry
5.9 Marketing Channel
5.9.1 Direct Marketing
5.9.2 Indirect Marketing
5.9.3 Marketing Channel Development Trend
6 Global Natural Killer Cells Therapeutics Market Segment by Type (2018-2025)
6.1 Global Natural Killer Cells Therapeutics Revenue ($) by Type (2018-2025)
6.2 Global Natural Killer Cells Therapeutics Sales by Type (2018-2025)
6.3 Global Natural Killer Cells Therapeutics Price by Type (2018-2025)
6.4 Global Natural Killer Cells Therapeutics Sales, Revenue ($) and Growth Rate by Type (2018-2025)
6.4.1 Global Natural Killer Cells Therapeutics Sales, Revenue ($) and Growth Rate of NK Cell Therapies (2018-2025)
6.4.2 Global Natural Killer Cells Therapeutics Sales, Revenue ($) and Growth Rate of NK Cell Directed Antibodies (2018-2025)
7 Global Natural Killer Cells Therapeutics Market Segment by Application (2018-2025)
7.1 Global Natural Killer Cells Therapeutics Revenue ($) by Application (2018-2025)
7.2 Global Natural Killer Cells Therapeutics Sales by Application (2018-2025)
7.3 Global Natural Killer Cells Therapeutics Sales and Growth Rate by Application (2018-2025)
7.3.1 Global Natural Killer Cells Therapeutics Sale, Revenue ($) and Growth Rate of Cancer (2018-2025)
7.3.2 Global Natural Killer Cells Therapeutics Sale, Revenue ($) and Growth Rate of Gastrointestinal Diseases (2018-2025)
7.3.3 Global Natural Killer Cells Therapeutics Sale, Revenue ($) and Growth Rate of Immunoproliferative Disorders (2018-2025)
8 Global Natural Killer Cells Therapeutics Market Segment by Region (2018-2025)
8.1 Global Natural Killer Cells Therapeutics Sales and Market Share, Region Wise (2018-2025)
8.2 Global Natural Killer Cells Therapeutics Revenue ($) and Market Share, Region Wise (2018-2025)
8.3 Global Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.4 United States Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.4.1 United States Natural Killer Cells Therapeutics SWOT Analysis
8.5 Europe Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.5.1 Europe Natural Killer Cells Therapeutics SWOT Analysis
8.6 China Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.6.1 China Natural Killer Cells Therapeutics SWOT Analysis
8.7 Japan Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.7.1 Japan Natural Killer Cells Therapeutics SWOT Analysis
8.8 India Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.8.1 India Natural Killer Cells Therapeutics SWOT Analysis
8.9 Southeast Asia Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.9.1 Southeast Asia Natural Killer Cells Therapeutics SWOT Analysis
8.10 Latin America Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.10.1 Latin America Natural Killer Cells Therapeutics SWOT Analysis
8.11 Middle East and Africa Natural Killer Cells Therapeutics Sales, Revenue ($), Price and Gross Margin (2018-2025)
8.11.1 Middle East and Africa Natural Killer Cells Therapeutics SWOT Analysis
9 Global Natural Killer Cells Therapeutics Market Forecast Segment by Type
9.1 Global Natural Killer Cells Therapeutics Revenue ($) and Sales Forecast by Type (2025-2033)
9.1.1 Global Natural Killer Cells Therapeutics Revenue ($) Forecast by Type (2025-2033)
9.1.2 Global Natural Killer Cells Therapeutics Sales Forecast by Type (2025-2033)
9.1.3 NK Cell Therapies Market Revenue ($) and Sales Forecast (2025-2033)
9.1.4 NK Cell Directed Antibodies Market Revenue ($) and Sales Forecast (2025-2033)
10 Global Natural Killer Cells Therapeutics Market Forecast Segment by Application
10.1 Global Natural Killer Cells Therapeutics Revenue ($) and Sales Forecast by Application (2025-2033)
10.1.1 Global Natural Killer Cells Therapeutics Revenue ($) Forecast by Application (2025-2033)
10.1.2 Global Natural Killer Cells Therapeutics Sales Forecast by Application (2025-2033)
10.1.3 Cancer Market Revenue ($) and Sales Forecast (2025-2033)
10.1.4 Gastrointestinal Diseases Market Revenue ($) and Sales Forecast (2025-2033)
10.1.5 Immunoproliferative Disorders Market Revenue ($) and Sales Forecast (2025-2033)
11 Global Natural Killer Cells Therapeutics Market Forecast Segment by Region
11.1 Global Natural Killer Cells Therapeutics Revenue ($) and Sales Forecast by Region (2025-2033)
11.1.1 Global Natural Killer Cells Therapeutics Sales Forecast by Region (2025-2033)
11.1.2 Global Natural Killer Cells Therapeutics Revenue ($) Forecast by Region (2025-2033)
11.2 North America Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.3 Europe Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.4 China Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.5 Japan Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.6 India Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.7 Southeast Asia Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.8 Latin America Market Revenue ($) and Growth Rate Forecast (2025-2033)
11.9 Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2025-2033)
12 Appendix
12.1 Methodology
12.2 Research Data Source
12.2.1 Secondary Data
12.2.2 Primary Data
12.2.3 Market Size Estimation
12.2.4 Legal Disclaimer
What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report